RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @UNMC_DrKhan: #NewSARS Immunology Great look at adaptive immunity. Ignore folks who interpret the detection of #SARS_CoV_2-reactive CD4(…
Fact..... ;) https://t.co/2aCxrN1x3s T cell immunity can be found in seronegative individuals. Asymptomatic infection can induce T cell immunity without Abs, also evidence of cross reactive T cell immunity with no prior exposure to SARS-COV2....
@CodyFulks @aginnt @ObsoleteDogma Not just SARS and MERS but other coronaviruses as well. And not just those in Asian countries. Here it looks like about 40-60% of the population has some protection from cross reactive T cells from previous CV infections,
RT @gerdosi: A great thread with several references that we’ve also covered. https://t.co/bBnAlp7bVs
@thereal_truther @provaxtexan @wirt_dan @ansgarjohn @MarioGonnet @plaforscience @FatEmperor @auscandoc @PeterFaberSP @PRider1980 @AlexBerenson @MLevitt_NP2013 @daniellevitt22 @yaneerbaryam Have you read about cell immunity? Do you have science disproving i
RT @gerdosi: A great thread with several references that we’ve also covered. https://t.co/bBnAlp7bVs
RT @UNMC_DrKhan: #NewSARS Immunology Great look at adaptive immunity. Ignore folks who interpret the detection of #SARS_CoV_2-reactive CD4(…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @VincentRK: Study in @CellPressNews found 70-100% of people recovering from COVID have good T cell immune responses targeting the spike…
RT @BenjaminMeyer85: 2. There are 2 different points that are discussed at the moment: First, there are some studies, i.e. https://t.co/Eh…
RT @gerdosi: A great thread with several references that we’ve also covered.
RT @VincentRK: Study in @CellPressNews found 70-100% of people recovering from COVID have good T cell immune responses targeting the spike…
#NewSARS Immunology Great look at adaptive immunity. Ignore folks who interpret the detection of #SARS_CoV_2-reactive CD4(+) T cells in ~40%-60% of unexposed individuals, suggesting cross-reaction to "common cold" coronaviruses, as herd immunity. https://
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
A great thread with several references that we’ve also covered.
Absolutely fascinating. 50% of individuals who had blood sampled *between 2015 and 2018* (so long before COVID-19) had T-Cell immunity to the novel virus.
RT @BenjaminMeyer85: 2. There are 2 different points that are discussed at the moment: First, there are some studies, i.e. https://t.co/Eh…
@aberron Ya, ya... pero es que desde el momento en el que los resultados del estudio de seroprevalencia no cuadraban ni por los cojones era evidente que faltaban piezas en el puzzle. Hay cosas publicadas al respecto hace meses ya. Esto fue sonado: https://
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
https://t.co/pEnR8r2RMS @jessaflecht @jessaflecht @GenoceaBio
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @jpablos91: Sorry por auto RT, pero para quienes están interesados en COVID y su inmunidad este paper es muy interesante. Aparte de pla…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @DiseaseEcology: Conclusion: A + antibody test from these commercial tests does NOT guarantee a strong neutralizing titre. How well it…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @BenjaminMeyer85: 2. There are 2 different points that are discussed at the moment: First, there are some studies, i.e. https://t.co/Eh…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
RT @counterchekist: @rdbishop83 @karolcummins @thespybrief - Antibodies in asymptomatic people faded over time. Symptomatic patients mainta…
RT @VincentRK: Study in @CellPressNews found 70-100% of people recovering from COVID have good T cell immune responses targeting the spike…
RT @BenjaminMeyer85: 2. There are 2 different points that are discussed at the moment: First, there are some studies, i.e. https://t.co/Eh…
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with C... https://t.co/Fp5OxsvrGY
RT @boriquagato: this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to o…
this is not how immunity here works. 30-60% of populations already had resistance via t-cell response (from exposure to other coronaviruses in the past) so his "analysis" is like saying "all the windows are locked" and missing the wide open front door.
@AstroMatze @MaryMieze @Karl_Lauterbach Das wäre dann neuer: https://t.co/KDdRzuI041
@GreenEy52389544 @boriquagato An earlier one here https://t.co/GZtt9FSLJS
@EricTopol Then why did infections drop off in NY? Data shows T cell levels are 2X antibody levels. Plus at least 2 papers show pre-existing immunity in 50% of the population. https://t.co/IL3wnSVxQc
RT @dockaurG: IMP @CellCellPress study of recovered non-hospitalized #COVID19 pts: #SARSCoV2 consistent w/normal antiviral immunity 100% m…
RT @Thomas_Wilckens: @Karl_Lauterbach Und dieser Artikel ist NICHT ganz neu; aber irgendwie passt das nicht in ihr Weltbild #Hintergrundimm…
RT @BenjaminMeyer85: 2. There are 2 different points that are discussed at the moment: First, there are some studies, i.e. https://t.co/Eh…
RT @Grund_gesetzt: Aufklärung zwecklos? Alles begann mit „Das neue Virus trifft auf keinerlei Immunität in der Bevölkerung.“ Jetzt wurde b…
Alejandro Bermejo Jose Manuel Cervera Grau DRA CAROLINA VAISMAN, PhD MSc Dra. Susana Infantes Esteban Mathias Goyen, Prof. https://t.co/gApsDOp4ov. FERNANDO FARIÑAS GUERRE@inmunopatologia Angel Ayuso-Sacido https://t.co/yEl4A0tiPy
RT @olivenews: SARS-CoV-2の表面にある突起であるスパイクたんぱく質を認識する「ヘルパーT細胞」が、すべての患者から検出された。また、スパイク状の突起以外のたんぱく質に反応するヘルパーT細胞も見つかった。そして70パーセントの患者からは、SARS-CoV-…
RT @DiseaseEcology: Conclusion: A + antibody test from these commercial tests does NOT guarantee a strong neutralizing titre. How well it…
@CHOMES102 @BenjaminMeyer85 @GidMK @DiseaseEcology @AVG_Joseph96 Could cross-reactivity also place some people at risk, given the role of cytokine storm in COVID-19? I think that's mentioned in the paper. https://t.co/JJ3bgpzbXF https://t.co/dLU5pVfgEg
Conclusion: A + antibody test from these commercial tests does NOT guarantee a strong neutralizing titre. How well it indicates actual protection, especially when combined with T-cell (which is partly correlated w/ Ab: https://t.co/47IeBXRNlk) & other
RT @counterchekist: @rdbishop83 @karolcummins @thespybrief - Antibodies in asymptomatic people faded over time. Symptomatic patients mainta…
RT @VincentRK: Study in @CellPressNews found 70-100% of people recovering from COVID have good T cell immune responses targeting the spike…
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Alba Grifoni et al (2020), May 14. https://t.co/xlLCnTQgJc https://t.co/59SrpTQ3vw
RT @DrSidMukherjee: 11/n Sorry, I meant the Grissoni paper in Cell https://t.co/0Qr0ZR1ndY
@EricVicenti It seems to be not as novel as thought at first. https://t.co/ca0qnbhxWD "Importantly, we detected SARS-CoV-2-reactive CD4+ T cells in ∼40%–60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating “common
2/ Last week, researchers in Sweden and Germany also found strong T-cell responses to #SARSCoV2 which bode well for long-term immunity & found pre-existing cross-protective immunity: findings are consistent with the original US Cell study published in
RT @olivenews: SARS-CoV-2の表面にある突起であるスパイクたんぱく質を認識する「ヘルパーT細胞」が、すべての患者から検出された。また、スパイク状の突起以外のたんぱく質に反応するヘルパーT細胞も見つかった。そして70パーセントの患者からは、SARS-CoV-…
T cell reactivity to SARS-CoV-2 epitopes is also detected in non-exposed individuals https://t.co/LJF2Fih4gk https://t.co/aj3ScmXuHd
2. There are 2 different points that are discussed at the moment: First, there are some studies, i.e. https://t.co/EhmRc34jQF, that show a cross-reactive T-cell response in sample taken before the pandemic, due to previous infection with common cold coron
RT @Rfonsi1: One of the first of such studies suggested that 50% of samples collected viably from 2015 to 2018 (pre-SARS-CoV-2) had this re…
RT @VincentRK: Study in @CellPressNews found 70-100% of people recovering from COVID have good T cell immune responses targeting the spike…
RT @VincentRK: Study in @CellPressNews found 70-100% of people recovering from COVID have good T cell immune responses targeting the spike…
RT @EricTopol: 5. One of the best studies to show the importance of T-cell immunity was published in @CellCellPress https://t.co/pwibwIupbB…
RT @EricTopol: 5. One of the best studies to show the importance of T-cell immunity was published in @CellCellPress https://t.co/pwibwIupbB…
RT @EricTopol: 5. One of the best studies to show the importance of T-cell immunity was published in @CellCellPress https://t.co/pwibwIupbB…
@TomasPerezAcle @jorgefabrega A menos que los tests no sean tan confiables, especialmente para los con síntomas leves (la mayoría): https://t.co/u0xvxdVx3G Y/o que la mitad de la población tenga inmunidad "natural" : https://t.co/QUUS8BIesz
@EricTopol But what if SARS-CoV-2-reactive CD4+ T cells get you half way to immunity? https://t.co/PkXbDnRjYc
RT @Nymne: Här konstaterar de OCKSÅ att en rätt stor andel helt enkelt saknar det CD8 T cellssvar som antas skydda från infektion. Detta be…
“We detected SARS-CoV-2-reactive CD4+ T cells in ∼40%–60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating “common cold” coronaviruses and SARS-CoV-2.” https://t.co/PaaYywLecy
RT @Nymne: Här konstaterar de OCKSÅ att en rätt stor andel helt enkelt saknar det CD8 T cellssvar som antas skydda från infektion. Detta be…
Här konstaterar de OCKSÅ att en rätt stor andel helt enkelt saknar det CD8 T cellssvar som antas skydda från infektion. Detta bekräftar alltså Stockholmsstudien. Det är konstigt. Jonathan Yewdell trodde detta var ett mätfel https://t.co/WDJfAxFkyq